Saitama
Japan
Saitama University - Saitama Medical University
Malignant mesothelioma, LAT1, prognosis, immunohistochemistry, predictive marker
non-small cell lung cancer, EGFR mutation, osimertinib, platinum-based chemotherapy, pemetrexed
ground-glass opacity, lepidic component, lung adenocarcinoma, Prognosis